Skip to main content
Home
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Chile
  • China
  • Colombia
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Netherlands
  • South Africa
  • Spain
  • Switzerland
  • Taiwan
  • United Kingdom
  • USA
  • Contact
  • English
  • French
GBT €8.76
  • Our Group
    • Guerbet in a nutshell
    • Our Corporate Responsibilities
    • Corporate Governance
    • Intrasense and Guerbet
      • Intrasense, a Guerbet Group subsidiary: Innovating in AI together
    • Careers
  • Products & Solutions
    MRI
    • Home of MRI Innovations
    • Artirem®
    • Dotarem®
    • Elucirem™ (Gadopiclenol)
    • Injectors, Accessories & Consumables
    • MRI Accessories
    • Consumables for Diagnostic Imaging
    • OptiStar® Elite
    • Ready-Box
    • Service & Support
    • OptiProtect™ 3S
    Diagnostic Imaging Interconnected Solutions…

    UNIK: Diagnostic Imaging Interconnected Solutions

    Explore our Solutions
    CT
    • Home of MRI Innovations
    • Conray® / Cysto-Conray®
    • Micropaque® / Microtrast®
    • Optiray®
    • Telebrix® Gastro
    • Xenetix® / ScanBag® by Xenetix®
    • Injectors, Accessories & Consumables
    • Consumables for Diagnostic Imaging
    • OptiBolus®
    • OptiOne™
    • OptiVantage™ Multi-use
    • OptiVantage™ Single-use
    • Ready-Box
    • Service & Support
    • OptiProtect™ 3S
    Diagnostic Imaging Interconnected Solutions…

    UNIK: Diagnostic Imaging Interconnected Solutions

    Explore our Solutions
    Cath Lab
    • Home of MRI Innovations
    • Optiray®
    • Xenetix® / ScanBag® by Xenetix®
    • Injectors, Accessories & Consumables
    • Consumables for Diagnostic Imaging
    • Illumena® Néo
    • Ready-Box
    • Service & Support
    • OptiProtect™ 3S
    Diagnostic Imaging Interconnected Solutions…

    UNIK: Diagnostic Imaging Interconnected Solutions

    Explore our Solutions
    Interventional Radiology
    • Pharmaceutical Drugs
    • Lipiodol® Ultra Fluid
    • Medical Devices
    • Qitexio®
    Solutions d’imagerie interventionnelle

    Interventional Imaging Solutions

    Explore our Solutions
    Women's Health
    • Pharmaceutical Drugs
    • Patent Blue V
    • Lipiodol® Ultra Fluid
    Fertility and women's health

    Women’s Health

    Explore our Solutions
  • Investors
    • Key Figures
    • Stock Performance
    • Financial Policy
    • Presentations, Reports & Regulated information
    • Agenda
    • General Meetings
  • Media
  • Educational Resources
  • Patient Resources
    • Blue November
    • Liver Cancer Awareness Month
    • Osteoarthritis
    • Vascular embolization
  • 100 years
    • Celebrating 100 years
    • Guerbet Saga
Insights

Featured stories

  1. Homepage
  2. Our Group
  3. Insights
Reducing the “everyday challenge” of non-target embolization

On-demand webinar: Cardiovascular CTA: tips and tricks in injection strategies for adult and pediatric

Read the article
Nuevos horizontes para el tratamiento del CHC…

Guerbet celebrates the International Day of Radiology (IDoR 2021)

Read the article
New horizons in fertility management: Exploring the role of hysterosalpingography on-demand

New horizons in fertility management: Exploring the role of hysterosalpingography on-demand

Read the article
Nuevos horizontes para el tratamiento del CHC…

CIRSE 2021 - Educational sessions replay

Read the article
Legal Information

Challenge your Expertise in Advanced Abdominal Clinical Cases

Read the article
Webinar: Role of MRI in breast cancer management - landscape and perspectives

Webinar: New horizons in infertility management – Use of contrast medium in hysterosalpingography

Read the article
Webinar - Lymphangiography - October 7

Webinar - Lymphangiography - October 7

Read the article
COVID-19

COVID-19

Read the article

MEET THE EXPERTS - Towards cTACE standardization

Read the article
  • ‹
  • 1
  • 2
  • Current page3
  • 4
  • 5
  • 6
  • ›
Image
Logo Guerbet
  • Legal Information
  • Cookie Policy
  • Data Protection Policy
  • Patents
  • Contact
Copyright © Guerbet
2026
  • LinkedIn
  • Twitter
  • Instagram
  • YouTube